INTRODUCTION
Malaria should be considered as a serious disease since it accounts for the death of around 3 million people every year. This disease remains as a major public health issue in our country due to slow progress in its control. Malaria is a disease caused by the parasites called 'Plasmodia' that lives part of its life in humans and part in mosquitoes. 1 Around 1.5 million cases of malaria are being reported annually by the National Vector Borne Disease Control Programme (NVBDCP), of which 50% are due to
P.falciparum. 2
Dakshina Kannada, a coastal district located on the western coast of Karnataka state was relatively free from malaria until early 1990 with only few cases. But since 1990, various industrial projects and other construction activities began with poor little care on hygienic aspects on due course there was an outbreak of malaria. It has been identified that the incidence of malaria increases with the onset of monsoon (June to October), as the water logging favors mosquito breeding and thus end up in transmission of the disease 3 .
Many states inhabited by ethnic tribes mainly in the forest ecosystems, malaria exist with the preponderance of P.falciparum 4 .
The greatest task is with the resistance of drug occurring with P.falciparum. It is necessary to take the guidance of the principles of clinical management o f malaria which include early recognition of infection due to P.falciparum and rapid management procedures. This in turn helps the physicians in easy overcome on complicated situations.
The main objective of the study was to understand the prescribing patterns and to compare it with the existing national guidelines for the management of malaria
MATERIALS AND METHODS
The study was conducted at K.S Hegde Charitable Hospital. It is a 750-beded private tertiary care hospital centrally located in Dakshina Kannada, Mangalore.
It is a retrospective cross-sectional study in which subjects admitted with a primary diagnosis of malaria during the one year period from June 2010 to May 2011 to study the clinical symptoms and the prescribing pattern of antimalarial drugs.
All patients above 15 years of age diagnosed to have malaria (after doing a peripheral blood smear) were included in the study. The study protocol was approved by the institutional human ethics committee.
The collected data includes 
RESULTS AND DISCUSSION

Demographics
In our study we have analyzed, 117 cases of confirmed malaria, admitted and treated in the hospital. Out of these, there were 95 (81.2%) males and 22 (18.8%) female patients. The age of the patients ranged from 15 years to 73 years. Majority of the people n=88 (75.2%) belong to the age group of 25-45 years. Though the ages of the subjects were different, malaria parasitaemia did not vary significantly between different age groups.
Seasonal variation
The cases of malaria admitted and treated during different seasonal variations in a calendar year, were studied and are mentioned in Table 1 . The highest frequency of cases was observed during the months of November and December (24%), and with the lowest rate of infection during the month of January (2.6%). A study conducted by Bonnlander et al at Central Haiti's Schweitzer hospital reported to have the peak case incidence occurred during November to January, a few months after the rainy season. 
Distribution of Plasmodium Species
A detailed distribution on the type of Plasmodium species among the diseased individuals is mentioned in 
Past medical history
Only 16 patients had the past medical history of malaria. Three of the patients showed relapse because of discontinuing treatment.
Clinical symptoms of malaria
The initial clinical features and other findings are summarized in Table 3 . Fever was the most commonly presented symptom by the patients and it accounted for all the cases (100% 
Comparison of symptoms according to plasmodia species
We have compared the presenting symptoms and clinical findings according to the parasite species. Abdominal symptoms including abdominal pain -9 (50%); vomiting -13 (72.2%); hepatomegaly -4 (22.2%) dominated in P.falciparum infection. The 'p' value on comparison with P.vivax for abdominal pain, vomiting and hepatomegaly in P.falciparum infection was 0.0242, 0.0487 and 0.0236 respectively and found the statistically significant difference. The details are depicted in Table 4 . A study based on the clinical features of malaria in Pakistan revealed that vomiting and abdominal pain occurred more frequently in patients infected with P.falciparum than any other parasites 8 .
Frequency of anti-malarial usage in various plasmodium species
Comparisons of drugs used among patients with malaria according to Plasmodium species was mentioned in Table  5 . In case of P.falciparum, the most commonly prescribed antimalarial was Artesunate 16 (88.9%), followed by Chloroquine 8 (44.4%) and Primaquine 8 (44.4%). For P.vivax, the most commonly administered drug was Chloroquine 61 (73.5%) followed by Primaquine 56 (67.5%) and Artesunate 19 (22.9%), and in case of mixed infections, the most commonly prescribed drug was Artesunate 13 (81.3) followed by Primaquine 10 (62.5%) and Chloroquine 8 (50.0%). 
Anti-malarial therapy based on WHO guidelines
We have conducted a comparison study on the antimalarial drug prescribing pattern with the WHO. In single drug therapy, Primaquine was the most prescribed anti-malarial drug (20.4%), followed by Chloroquine (7.2%), Artesunate (3.8%), and Arteether (1.3%), irrespective of the type of therapy. In combined drug therapy Chloroquine with Doxycycline (10%), Artesunate with Doxycycline (8.2%), Artesunate with Sulphadoxine/Pyrimethamine (12%) were prescribed and considered as rational in accordance with WHO. Thus, 78.7% of these cases have been treated in accordance with the WHO norms. The study result also shows the drug therapeutical management of the remaining 21.3% of cases was not according to the WHO norms. We have observed the inappropriate combinations in antimalarial drug therapy w h i c h include (20.7%) and an inappropriate choice of anti-malarial drug at the rate of (0.6%) during the study (Table 6) . A Similar study report also suggested that Chloroquine with Sulphadoxine/Pyrimethamine is not a suitable combination especially in first-line treatment of P.falciparum 9 . A study by Abuaku B K et al found that inappropriate doses of chloroquine prescriptions were more in private than government health care systems 10 . Chloroquine was the most commonly prescribed antimalarial drug during this study period. Due to raising fear of resistance, multidrug approach has been tried in majority of cases and thereby helped in preventing resistance and serious complications. We have observed that 78.7% of these cases have been given treatment according to WHO guidelines and the remaining did not.
There is a need for special treatment protocol for malarial based on the different plasmodium species and for drug resistant malaria in this particular locality. It is suggested that adequate vector control measures associated with active surveillance will certainly reduce the malaria transmission in this region. Moreover, Implementation of regular training programs, workshops and other modes, to enhance the prescriprition patterns among prescribers should be encouraged for better patient care.
